Artemisia herba-alba sesquiterpenes: in silico inhibition in the ATP-binding pocket
- PMID: 37388153
- PMCID: PMC10301712
- DOI: 10.1039/d3ra02690f
Artemisia herba-alba sesquiterpenes: in silico inhibition in the ATP-binding pocket
Abstract
To identify antimicrobial leads for medical applications, metabolites from the aerial part of Artemisia herba-alba were extracted and chromatographically purified. Two new sesquiterpenes, 1β,8α-dihydroxyeudesm-4-en-6β,7α,11βH-12,6-olide (1) and 1β,6α,8α-trihydroxy, 11α-methyl-eudesma-4(15)-en-13-propanoate (2) along with a known eudesmanolide 11-epi-artapshin (3) were identified. Structures were determined by spectroscopic methods including 1D- and 2D-NMR as well as mass spectroscopy. Compound 3 inhibited Gram-positive bacteria Bacillus subtilis, Lactobacillus cereus and Staphylococcus aureus and exhibited antifungal activity against the pathogenic fungus F. solani. The mode-of-action of these antimicrobial sesquiterpenes as bacterial type II DNA topoisomerase and/or DNA gyrase B inhibitors were examined via in silico studies. Such molecular-docking studies were also employed to examine antifungal activity against an N-myristoyl transferase (NMT) target. Compound 3 had the greatest gyrase B binding affinity in the ATP-binding pocket and was found to possess an inhibitory action against non-invasive micro-test technology (NMT).
This journal is © The Royal Society of Chemistry.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
References
-
- Newman D. J. Cragg G. M. J. Nat. Prod. 2016;79:629–661. - PubMed
-
- Pan S.-Y. Litscher G. Gao S.-H. Zhou S.-F. Yu Z.-L. Chen H.-Q. Zhang S.-F. Tang M.-K. Sun J.-N. Ko K.-M. Evid.-Based Complementary Altern. Med. 2014;2014:1–20.
-
- Anand U. Nandy S. Mundhra A. Das N. Pandey D. K. Dey A. Drug Resistance Updates. 2020;51:100695. - PubMed
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous
